C. difficile - Clostridium difficile

Novacta targets C. difficile the natural way

Interviewee/Contributer: Tony Sedgwick

Organisation: Novacta Biosystems Ltd

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Novacta targets C. difficile the natural way

Interviewee/Contributer: Michael Dawson

Organisation: Novacta Biosystems Ltd

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Syndicate content